The Objectives of This Study Are Study of the Reactogenicity, Safety and Immunogenicity of Flu-M Inactivated Split Influenza Vaccine in Volunteers Aged 18-60 Years
PHASE1
Study of the Reactogenicity, Safety and Immunogenicity of Flu-M Inactivated...
Status
Completed
Location
Perm State Medical University named after academician E.A. Wagner
Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and Older
PHASE1
Study VBT00001 is planned to be a Phase 1/2, randomized, modified double-bl...
Status
Completed
Location
Simon Williamson Clinic - Birmingham- Site Number : 8400003
The Objectives of This Study Are Comparative Assessment of the Tolerability, Safety and Immunogenicity of the Flu-M Vaccine vs. the Ultrix® Vaccine by Single Vaccination of Children Aged 6 to 17 Years.
PHASE3
Comparative assessment of the tolerability, safety and immunogenicity of th...
Status
Completed
Location
Perm State Medical University named after Academician E. A. Wagner
The Objectives of This Study Are Study the Safety, Reactogenicity and Obtain Preliminary Data on the Immunogenicity of Flu-M Quadro, 4-valent Inactivated Split Influenza Vaccine, in Healthy Volunteers
PHASE1
The study the safety, reactogenicity and obtain preliminary data on the imm...
Status
Completed
Location
Federally Funded Healthcare Institution Primary Healthcare Unit No. 163